Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing

Autor: Daniel J. Drucker, Rémy Burcelin, Miguel A. Iglesias, Dong Hoon Kim, Aurélie Waget, Patrice D. Cani, Sophie Rastrelli, André Colom, Claude Knauf, Nathalie M. Delzenne, Randy J. Seeley, Chantal Chabo
Přispěvatelé: Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Unit of Pharmacokinetics, Metabolism, Nutrition, and Toxicology (PMNT-73/69), Université Catholique de Louvain = Catholic University of Louvain (UCL), Department of Psychiatry, University of Cincinnati (UC)-Genome Research Institute, Banting and Best Diabetes Centre, Samuel Lunenfeld Research Institute-Mt. Sinai Hospital, University of Toronto, UCL - MD/FARM - Ecole de pharmacie, Simon, Marie Francoise, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Blood Glucose
Central Nervous System
Endocrinology
Diabetes and Metabolism

MESH: Glycogen
MESH: Mice
Knockout

chemistry.chemical_compound
Mice
0302 clinical medicine
Glucagon-Like Peptide 1
Receptors
Glucagon

Glucose homeostasis
Insulin
MESH: Animals
Receptor
Mice
Knockout

0303 health sciences
MESH: Muscle
Skeletal

Glycogen
MESH: Proto-Oncogene Proteins c-fos
digestive
oral
and skin physiology

Brain
Glucagon-like peptide-1
Immunohistochemistry
MESH: Glucose
Liver
Hypothalamus
Proto-Oncogene Proteins c-fos
medicine.medical_specialty
Neuropeptide
030209 endocrinology & metabolism
MESH: Insulin
Carbohydrate metabolism
Biology
Glucagon-Like Peptide-1 Receptor
03 medical and health sciences
MESH: Receptors
Glucagon

MESH: Brain
MESH: Mice
Inbred C57BL

Internal medicine
Internal Medicine
medicine
Animals
MESH: Central Nervous System
Glycogen synthase
Muscle
Skeletal

MESH: Mice
030304 developmental biology
MESH: Glucagon-Like Peptide 1
MESH: Immunohistochemistry
Mice
Inbred C57BL

Metabolism
Endocrinology
Glucose
chemistry
biology.protein
MESH: Blood Glucose
MESH: Liver
Zdroj: Diabetes
Diabetes, American Diabetes Association, 2008, 57 (10), pp.2603-12. ⟨10.2337/db07-1788⟩
Diabetes, Vol. 57, no. 10, p. 2603-2612 (2008)
Diabetes, 2008, 57 (10), pp.2603-12. ⟨10.2337/db07-1788⟩
ISSN: 0012-1797
1939-327X
Popis: OBJECTIVE—Ingested glucose is detected by specialized sensors in the enteric/hepatoportal vein, which send neural signals to the brain, which in turn regulates key peripheral tissues. Hence, impairment in the control of enteric-neural glucose sensing could contribute to disordered glucose homeostasis. The aim of this study was to determine the cells in the brain targeted by the activation of the enteric glucose-sensing system. RESEARCH DESIGN AND METHODS—We selectively activated the axis in mice using a low-rate intragastric glucose infusion in wild-type and glucagon-like peptide-1 (GLP-1) receptor knockout mice, neuropeptide Y–and proopiomelanocortin–green fluorescent protein–expressing mice, and high-fat diet diabetic mice. We quantified the whole-body glucose utilization rate and the pattern of c-Fos positive in the brain. RESULTS—Enteric glucose increased muscle glycogen synthesis by 30% and regulates c-Fos expression in the brainstem and the hypothalamus. Moreover, the synthesis of muscle glycogen was diminished after central infusion of the GLP-1 receptor (GLP-1Rc) antagonist Exendin 9-39 and abolished in GLP-1Rc knockout mice. Gut-glucose–sensitive c-Fos–positive cells of the arcuate nucleus colocalized with neuropeptide Y–positive neurons but not with proopiomelanocortin-positive neurons. Furthermore, high-fat feeding prevented the enteric activation of c-Fos expression. CONCLUSIONS—We conclude that the gut-glucose sensor modulates peripheral glucose metabolism through a nutrient-sensitive mechanism, which requires brain GLP-1Rc signaling and is impaired during diabetes.
Databáze: OpenAIRE